2,3,7,8-Tetrachlorodibenzo-p-dioxin Reduces Myocardial Hypoxia and Vascular Endothelial Growth Factor Expression during Chick Embryo Development

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 70, Issue 2, 2004, Pages 51-58

  Ivnitski Steele, Irena D ^a   Sanchez, Andrea ^a   Walker, Mary K ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Coronary vasculogenesis; Dioxin; Embryo; Heart; Hypoxia; VEGF

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CELL MARKER; CORN OIL; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; PROTEIN EF5; SODIUM CHLORIDE; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CHICK EMBRYO; CONTROLLED STUDY; CORONARY ARTERY; EGG; EMBRYO; EMBRYO DEVELOPMENT; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART VENTRICLE WALL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INCUBATION TIME; NONHUMAN; OXYGEN TISSUE LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOXICITY TESTING;

ANIMALS; CELL HYPOXIA; CHICK EMBRYO; ENVIRONMENTAL POLLUTANTS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MYOCYTES, CARDIAC; RNA, MESSENGER; TETRACHLORODIBENZODIOXIN; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ZEA MAYS;

EID: 1542366424     PISSN: 15420752     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdra.10151     Document Type: Article

References (40)

1. Akimoto T, Liapis H, Hammerman MR. 2002. Microvessel formation from mouse embryonic aortic explants is oxygen and VEGF dependent. Am J Physiol Regul Integr Comp Physiol 283:R487-R495.
2. Akita T, Murohara T, Ikeda H, et al. 2003. Hypoxic preconditioning augments efficacy of human endothelial progenitor cells for therapeutic neovascularization. Lab Invest 83:65-73.
3. Banai S, Shweiki D, Pinson A, et al. 1994. Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc Res 28:1176-1179.
4. Canga L, Paroli L, Blanck TJ, et al. 1993. 2,3,7,8-tetrachlorodibenzo-p-dioxin increases cardiac myocyte intracellular calcium and progressively impairs ventricular contractile responses to isoproterenol and to calcium in chick embryo hearts. Mol Pharmacol 44:1142-1151.
5. Catron T, Mendiola MA, Smith SM, et al. 2001. Hypoxia regulates avian cardiac Arnt and HIF-1alpha mRNA expression. Biochem Biophys Res Commun 282:602-607.
6. Chen EY, Fujinaga M, Giaccia AJ. 1999. Hypoxic microenvironment within an embryo induces apoptosis and is essential for proper morphological development. Teratology 60:215-225.
7. Cheung MO, Gilbert EF, Peterson RE. 1981. Cardiovascular teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the chick embryo. Toxicol Appl Pharmacol 61:197-204.
8. Claffey KP, Shih SC, Mullen A, et al. 1998. Identification of a human VPF/VEGF 3′ untranslated region mediating hypoxia-induced mRNA stability. Mol Biol Cell 9:469-481.
9. Damert A, Machein M, Breier G, et al. 1997. Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms. Cancer Res 57:3860-3864.
10. Evans SM, Hahn SM, Magarelli DP, Koch CJ. 2001. Hypoxic heterogeneity in human tumors: EF5 binding, vasculature, necrosis, and proliferation. Am J Clin Oncol 24:467-472.
11. Fan L, Ovadia M, Friedman DM, Rifkind AB. 2000. Ventricular preexcitation sensitive to flecainide in late stage chick embryo ECGs: 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs inotropic but not chronotropic or dromotropic responses to isoproterenol and confers resistance to flecainide. Toxicol Appl Pharmacol 166:43-50.
12. Geva E, Ginzinger DG, Zaloudek CJ, et al. 2002. Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2. J Clin Endocrinol Metab 87:4213-4224.
13. Giordano FJ, Gerber HP, Williams SP, et al. 2001. A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci USA 98:5780-5785.
14. Henshel DS, Hehn BM, Vo MT, Steeves JD. 1993. A short-term test for dioxin teratogenicity using chicken embryos. In: Gorsuch JW, Dwyer FJ, Ingersoll CG, LaPoint TW, editors. Environmental toxicology and risk assessment. American Society for Testing and Materials. Philadelphia2. pp. 159-174.
15. Ivnitski I, Elmaoued R, Walker MK. 2001. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) inhibition of coronary development is preceded by a decrease in myocyte proliferation and an increase in cardiac apoptosis. Teratology 64:201-212.
16. Ivnitski-Steele I, Walker MK. 2003. Vascular endothelial growth factor rescues 2,3,7,8-tetrachlorodibenzo-p-dioxin inhibition of coronary vasculogenesis. Birth Defects Res Part A Clin Mol Teratol 67:496-503.
17. Jung F, Palmer LA, Zhou N, Johns RA. 2000. Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes. Circ Res 86:319-325.
18. Kotch LE, Iyer NV, Laughner E, Semenza GL. 1999. Defective vascularization of HIF-1alpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death. Dev Biol 209:254-267.
19. Lee YM, Jeong CH, Koo SY, et al. 2001. Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: a possible signal for vessel development. Dev Dyn 220:175-186.
20. Levy AP, Levy NS, Wegner S, Goldberg MA. 1995. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 270:13333-13340.
21. Li J, Brown LF, Hibberd MG, et al. 1996. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol 270: H1803-H1811.
22. Liu Y, Cox SR, Morita T, Kourembanas S. 1995. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. Circ Res 77:638-643.
23. Marti HH, Risau W. 1998. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc Natl Acad Sci USA 95:15809-15814.
24. Phillips PG, Birnby LM, Narendran A. 1995. Hypoxia induces capillary network formation in cultured bovine pulmonary microvessel endothelial cells. Am J Physiol 268:L789-L800.
25. Powell DC, Aulerich RJ, Meadows JC, et al. 1996. Effects of 3,3′,4,4′,5-pentachlorobiphenyl (PCB 126) and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) injected into the yolks of chicken (Gallus domesticus) eggs prior to incubation. Arch Environ Contam Toxicol 31:404-409.
26. Reese DE, Mikawa T, Bader DM. 2002. Development of the coronary vessel system. Circ Res 91:761-768.
27. Rifkind AB, Sassa S, Reyes J, Muschick H. 1985. Polychlorinated aromatic hydrocarbon lethality, mixed-function oxidase induction, and uroporphyrinogen decarboxylase inhibition in the chick embryo: dissociation of dose-response relationships. Toxicol Appl Pharmacol 78:268-279.
28. Risau W. 1997. Mechanisms of angiogenesis [Review]. Nature 386:671-674.
29. Semenza GL. 2000. Expression of hypoxia-inducible factor 1: mechanisms and consequences [Review]. Biochem Pharmacol 59:47-53.
30. Semenza GL. 2003. Angiogenesis in ischemic and neoplastic disorders [Review]. Annu Rev Med 54:17-28.
31. Shapiro IM, Mansfield KD, Evans SM, et al. 1997. Chondrocytes in the endochondral growth cartilage are not hypoxic. Am J Physiol 272: C1134-C1143.
32. Stroka DM, Burkhardt T, Desbaillets I, et al. 2001. HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J 15:2445-2453.
33. Tomanek RJ, Ratajska A, Kitten GT, et al. 1999. Vascular endothelial growth factor expression coincides with coronary vasculogenesis and angiogenesis. Dev Dyn 215:54-61.
34. Tucci M, Hammerman SI, Furfaro S, et al. 1997. Distinct effect of hypoxia on endothelial cell proliferation and cycling. Am J Physiol 272:C1700-C1708.
35. Vanden Heuvel JP, Tyson FL, Bell DA. 1993. Construction of recombinant RNA templates for use as internal standards in quantitative RT-PCR. Biotechniques 14:395-398.
36. Vanden Heuvel JP. 1998. Analysis of gene expression. In: Vanden Heuvel JP, editor. PCR protocols in molecular toxicology. Boca Raton: CRC Press. pp. 41-97.
37. Walker MK, Pollenz RS, Smith SM. 1997. Expression of the aryl hydrocarbon receptor (AhR) and AhR nuclear translocator during chick cardiogenesis is consistent with 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced heart defects. Toxicol Appl Pharmacol 143:407-419.
38. Walker MK, Catron TF. 2000. Characterization of cardiotoxicity induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related chemicals during early chick embryo development. Toxicol Appl Pharmacol 167:210-221.
39. Walker MK, Heid SE, Smith SM, Swanson HI. 2000. Molecular characterization and developmental expression of the aryl hydrocarbon receptor from the chick embryo. Comp Biochem Physiol C Toxicol Pharmacol 126:305-319.
40. Yue X, Tomanek RJ. 1999. Stimulation of coronary vasculogenesis/angiogenesis by hypoxia in cultured embryonic hearts. Dev Dyn 216:28-36.